PATENT CLAIM ANALYSIS

Application Number: 15917926
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "186100"]

Abstract:
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.

Claim (Index 61):
The host cell of  claim 56 , wherein the host cell is modified to express a 2,6-sialic acid receptor.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.91429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14128415', '15681613', '15125763', '13131733', '15538133']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.830893203875097
- 35 USC 102 Novelty (BERT): 0.5757567470534273
- Combined Prediction Score: 0.8053795581929301
- Mean Citation Score: 544.6996519999999
- Max Citation Score: 690.3398
- Similarity Product: 363.8937218350172

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test